ACI-24.060

N/A

Report date: 2023/06/29 13:48:24

Base Information

Drug NameACI-24.060
Drug Alias NamePal1-15 acetate saltAnti-Abeta vaccineACI-24ACI-24.060
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsTumor protein p53 inhibitors
TargetsTumor protein p53
Therapy Area/IndicationsPlaque, AmyloidDown SyndromeAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune SaTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque, AmyloidAlzheimer Disease
Inactive IndicationsDown Syndrome

Other Information

ATC CodeN/A
Related LinksN/A